Cancer Drug Resistance 2023 Annual Progress Report – Remarkable Highlights
The Cancer Drug Resistance (CDR) journal, a leading publication in the field of cancer research, is delighted to announce the release of its Annual Progress Report for 2023, showcasing a year of remarkable strides and achievements.
Cancer Drug Resistance remains dedicated to advancing the understanding of drug resistance in cancer and anticipates continued success in the years ahead.
Cancer Drug Resistance Annual Progress Report 2023 download link:
Editor: Louise Pan
Language Editor: Catherine Yang
Production Editor: Yan Zhang
Respectfully Submitted by the Editorial Office of Cancer Drug Resistance